Target intelligence / Profile preview

Opsonins and pattern-recognition components of the mononuclear phagocyte system

Molecular classification
Receptor, Soluble protein, Complement system, Pattern recognition receptor
01

Overview

The "Opsonins and pattern-recognition components of the mononuclear phagocyte system" refers to a broad functional category of molecules and receptors that mediate the innate immune response within monocytes, macrophages, and dendritic cells (Janeway et al., 2016). Opsonins, including complement proteins like C3b and various immunoglobulins, serve as molecular tags that facilitate the recognition and engulfment of pathogens by phagocytic receptors such as Fc receptors and complement receptors (Abbas et al., 2021). Pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs), are specialized to detect conserved microbial motifs known as pathogen-associated molecular patterns (PAMPs) (Medzhitov, 2007). This system is essential for host defense, the initiation of inflammation, and the clearance of apoptotic cells to maintain tissue homeostasis. Dysregulation of these components is a hallmark of sepsis, chronic inflammatory diseases, and autoimmune conditions (Ricklin et al., 2010). While the system as a whole is not a single drug target, specific components are targeted by therapeutic agents; for example, eculizumab inhibits the complement protein C5, and imiquimod acts as an agonist for TLR7 to treat various conditions (StatPearls, 2023).

Other names
Pattern recognition receptorsPRRsOpsonin receptorsMPS componentsInnate immune recognition system
02

Mechanism of action

Modulation of innate immune recognition, enhancement or inhibition of phagocytosis, and regulation of inflammatory signaling pathways.

03

Biological functions

Immune responsePhagocytosisPathogen recognitionInflammationApoptotic cell clearance
04

Disease associations

InfectionAutoimmune diseaseInflammationSepsisCancer
05

Safety considerations

Increased risk of opportunistic infectionsCytokine release syndromeInfusion-related reactionsAutoimmunity due to impaired clearance
06

Interacting drugs

Eculizumab

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Complement C3/C4 levelsPro-inflammatory cytokines (TNF-alpha, IL-6)Soluble CD14

Beyond the preview

Go deeper on Opsonins and pattern-recognition components of the mononuclear phagocyte system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opsonins and pattern-recognition components of the mononuclear phagocyte system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call